The Global Globin Network (GGN) is a project-wide initiative of the Human Variome/Global
Variome Project (HVP) focusing on haemoglobinopathies to build the capacity for genomic …

Disease registries can be extremely powerful evidence generating tools while providing a
central meeting point for all implicated stakeholders, facilitating their networking and …

Haemoglobinopathies, including thalassaemias and sickle-cell syndromes, are demanding,
lifelong conditions that pose a significant burden to patients, families, and healthcare …

Background Anemia is a significant contributor to the global disease burden, of which
thalassemia is the most common hereditary anaemic disease. Previous estimates were …

Hemoglobin disorders (thalassemia and sickle cell disease) are a group of hereditary
anemias that today occur across the world. The recent population movement has led to a …

Hemoglobin (Hb) disorders are common, potentially lethal monogenic diseases, posing a
global health challenge. With worldwide migration and intermixing of carriers, demanding …

Background and Objectives: The effective management of chronic diseases, particularly
hereditary and rare diseases and thalassaemia, is an important indicator of the quality of …

To demonstrate a method for using genetic epidemiological data to assess the needs for
equitable and cost-effective services for the treatment and prevention of haemoglobin …

Haemoglobinopathies are the commonest monogenic diseases, with millions of carriers and
patients worldwide. Online resources for haemoglobinopathies are largely divided into …

Haemoglobinopathies are hereditary disorders affecting the structure, function or production
of haemoglobin (Hb) and are among the commonest of clinically significant monogenic …